ELAN — Elanco Animal Health Balance Sheet
0.000.00%
- $10.58bn
- $14.25bn
- $4.44bn
- 62
- 44
- 99
- 78
Annual balance sheet for Elanco Animal Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 495 | 638 | 345 | 352 | 468 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,077 | 1,028 | 1,002 | 1,010 | 886 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,417 | 3,276 | 3,279 | 3,407 | 3,215 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,503 | 1,222 | 1,140 | 1,166 | 1,115 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,693 | 16,483 | 15,491 | 14,362 | 12,614 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,076 | 1,643 | 1,702 | 1,241 | 1,315 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,217 | 8,945 | 8,202 | 8,139 | 6,518 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 8,476 | 7,538 | 7,289 | 6,223 | 6,096 |
| Total Liabilities & Shareholders' Equity | 17,693 | 16,483 | 15,491 | 14,362 | 12,614 |
| Total Common Shares Outstanding |